S2 Genomics

About:

S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications.

Website: https://s2genomics.com

Twitter/X: s2genomics

Top Investors: HealthTech Capital, Life Science Angels, BroadOak Capital Partners, Research Corporation Technologies

Description:

S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomic analyses. S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.